Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled
Combivent® CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.